142 related articles for article (PubMed ID: 7107070)
1. Corynebacterium parvum prevents immunization to admixed irradiated tumor cells by a local process.
Titus MJ; Bartlett GL; Kreider JW
Int J Cancer; 1982 Jun; 29(6):699-705. PubMed ID: 7107070
[TBL] [Abstract][Full Text] [Related]
2. Active, specific immunotherapy of murine leukemia. II. Adjuvant effect of Corynebacterium parvum.
Bartlett GL; Kreider JW
Int J Cancer; 1979 Nov; 24(5):636-43. PubMed ID: 528079
[TBL] [Abstract][Full Text] [Related]
3. Treatment of cancer using Corynebacterium parvum: similarity of two preparations in four animal tumor models.
Bartlett GL; Kreider JW; Purnell DM
Cancer; 1980 Aug; 46(4):685-91. PubMed ID: 7397633
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of purified cell walls from Corynebacterium parvum.
Riveros-Moreno V; Bomford R; Scott MT
J Natl Cancer Inst; 1978 Mar; 60(3):653-8. PubMed ID: 625069
[TBL] [Abstract][Full Text] [Related]
5. Immunity to transplantable nitrosourea-induced neurogenic tumors. I. Potentiation of tumor immunity with Corynebacterium parvum.
Cravioto HM; DeBernardo E; Hochwald GM; Thorbecke JG
J Neuropathol Exp Neurol; 1981 Sep; 40(5):526-36. PubMed ID: 7276992
[TBL] [Abstract][Full Text] [Related]
6. Tumor-specific T-lymphocyte cytotoxicity enhanced by low dose of C. parvum.
Lau BH; Wang-Cheng RM; Tosk J
J Leukoc Biol; 1987 May; 41(5):407-11. PubMed ID: 3494802
[TBL] [Abstract][Full Text] [Related]
7. Effects of Corynebacterium parvum alone and in combination with adriamycin in experimental tumor systems.
Houchens DP; Johnson RK; Ovejera A; Gaston MR; Goldin A
Cancer Treat Rep; 1976 Jul; 60(7):823-8. PubMed ID: 1009517
[TBL] [Abstract][Full Text] [Related]
8. Relationship between intradermal tumor suppression and tumor immunity.
Bartlett GL; Kreider JW; Purnell DM
J Natl Cancer Inst; 1976 Dec; 57(6):1297-303. PubMed ID: 794505
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of anti-tumor action of Corynebacterium parvum. I. Potentiated tumor-specific immunity and its therapeutic limitations.
Dye ES; North RJ; Mills CD
J Exp Med; 1981 Sep; 154(3):609-20. PubMed ID: 6974214
[TBL] [Abstract][Full Text] [Related]
10. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
Likhite VV
J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of the tumor-specific immune response by Corynebacterium parvum.
Scott MT
J Natl Cancer Inst; 1975 Jul; 55(1):65-72. PubMed ID: 808637
[TBL] [Abstract][Full Text] [Related]
12. Effects of Corynebacterium parvum on murine myeloid leukaemia.
Bjornsson S; Preisler H; Pavelic Z
Br J Cancer; 1978 Dec; 38(6):703-8. PubMed ID: 217398
[TBL] [Abstract][Full Text] [Related]
13. Combination of C. parvum and specific immunization against artificial pulmonary metastases in mice.
Milas L; Kogelnik HD; Basic I; Mason K; Hunter N; Withers HR
Int J Cancer; 1975 Nov; 16(5):738-46. PubMed ID: 1184241
[TBL] [Abstract][Full Text] [Related]
14. Biological effects of Corynebacterium parvum. 3. Amplification of resistance and impairment of active immunity to murine tumours.
Smith SE; Scott MT
Br J Cancer; 1972 Oct; 26(5):361-7. PubMed ID: 4343677
[TBL] [Abstract][Full Text] [Related]
15. Antitumor immunity induced by hybrid murine tumor cells: requirements for optimal immunization.
McCune CS; O'Donnell RW; Horan PK; Budd HS; Spennacchio JL; Chuang C; Henshaw EC
J Natl Cancer Inst; 1982 Sep; 69(3):647-52. PubMed ID: 6955557
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of anti-tumor action of Corynebacterium parvum. II. Potentiated cytolytic T cell response and its tumor-induced suppression.
Mills CD; North RJ; Dye ES
J Exp Med; 1981 Sep; 154(3):621-30. PubMed ID: 6974215
[TBL] [Abstract][Full Text] [Related]
17. Lymphocytes generated by in vivo priming and in vitro sensitization demonstrate therapeutic efficacy against a murine tumor that lacks apparent immunogenicity.
Shu SY; Chou T; Sakai K
J Immunol; 1989 Jul; 143(2):740-8. PubMed ID: 2738408
[TBL] [Abstract][Full Text] [Related]
18. Effect of Corynebacterium parvum on tumor growth in normal and athymic (nude) mice.
Woodruff MF; Warner NL
J Natl Cancer Inst; 1977 Jan; 58(1):111-6. PubMed ID: 299893
[TBL] [Abstract][Full Text] [Related]
19. Immunopotentiation of cell-mediated hypersensitivity by Corynebacterium parvum (Propionibacterium acnes).
Maguire HC; Cipriano D
Int Arch Allergy Appl Immunol; 1983; 70(1):34-9. PubMed ID: 6848475
[TBL] [Abstract][Full Text] [Related]
20. Vaccination of adult and newborn mice of a resistant strain (C57BL/6J) against challenge with leukemias induced by Moloney murine leukemia virus.
Reif AE
Cancer Res; 1985 Jan; 45(1):25-31. PubMed ID: 3965136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]